Modification of mammalian reoviruses for use as oncolytic agents

Expert Opinion on Biological Therapy
D J M van den WollenbergR C Hoeben

Abstract

The Reoviridae are a family of viruses with a non-enveloped icosahedral capsid and a segmented double-stranded RNA genome. Prototypes of the mammalian Orthoreoviruses have been isolated from human respiratory and enteric tracts and are not associated with human disease. One of these, human reovirus type 3 Dearing (T3D), usually serves as a model for the family. In the last decade the mammalian Orthoreoviruses, especially T3D, have been evaluated as oncolytic agents in experimental cancer therapy. This is based on the observation that reoviruses induce cell death and apoptosis in tumor cells, but not in healthy non-transformed cells. Several clinical trials have been initiated in Canada, the USA, and the UK, to study the feasibility and safety of this approach. Due to the segmented structure of their double-stranded RNA genomes genetic modification of Reoviridae has been notoriously difficult. Several techniques have been described recently that facilitate the genetic modification of reovirus genomes. The basis for reverse genetics of reovirus is the discovery in 1990 that reovirus RNA is infectious. Subsequently, it took ten years before a foreign gene was introduced into the reovirus genome. Here we review the methods for reov...Continue Reading

References

Jul 1, 1978·Journal of the National Cancer Institute·J C TheissA J Kniazeff
Dec 1, 1990·Virology·M R RonerW K Joklik
Jan 1, 1988·Cancer Immunology, Immunotherapy : CII·J S Bryson, D C Cox
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·M R RonerW K Joklik
Nov 13, 1998·Science·M C CoffeyP W Lee
Apr 20, 2000·The Journal of Clinical Investigation·K L Norman, P W Lee
Oct 31, 2000·The Journal of Biological Chemistry·E S BartonT S Dermody
Mar 10, 2001·Cell·E S BartonT S Dermody
Jun 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·M R Roner, W K Joklik
Mar 11, 2003·Reviews in Medical Virology·Thilo Stehle, Terence S Dermody
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Andrea E ProtaThilo Stehle
Oct 22, 2003·Canadian Journal of Microbiology·Etienne Rouault, Guy Lemay
Apr 10, 2004·Science·Alicia E Smith, Ari Helenius
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kara L NormanPatrick W K Lee
Aug 31, 2004·BMC Cell Biology·Jinsong ShengDonald H Rubin
Nov 4, 2004·BMC Cell Biology·Edward L OrganDonald H Rubin
Jun 23, 2005·Drug Discovery Today·Kara L Norman, Patrick W K Lee
Feb 8, 2006·Spinal Cord·P PatkiM Craggs
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Satoshi KomotoKoki Taniguchi
Mar 18, 2006·Cancer Gene Therapy·N SmakmanO Kranenburg
Aug 17, 2006·Current Topics in Microbiology and Immunology·K M GuglielmiT S Dermody
Aug 31, 2006·Journal of Virology·Takeshi KobayashiTerence S Dermody
Sep 22, 2006·Virology·Michael R Roner, Bradley G Steele
Oct 20, 2006·Journal of Virological Methods·Michael R Roner, Christine Mutsoli
Dec 8, 2006·Journal of Virology·Mark Boyce, Polly Roy
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anthony T PowerJohn C Bell
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Patrick F KellyDavid A Williams
Jan 30, 2007·Nature Clinical Practice. Oncology·Ta-Chiang LiuDavid Kirn
Mar 27, 2007·Cancer Letters·Markus J V Vähä-KoskelaAri E Hinkkanen
Apr 26, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paola MarcatoPatrick Wk Lee
May 24, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tommy AlainPeter A Forsyth

❮ Previous
Next ❯

Citations

Jun 21, 2012·Pathology Oncology Research : POR·Md ZeyaullahArif Ali
Apr 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elizabeth M HadacStephen J Russell
Oct 16, 2010·Nucleic Acids Research·Chantal HuloPhilippe Le Mercier
Oct 6, 2012·Molecular Cancer Research : MCR·Radhashree MaitraSanjay Goel
Jun 21, 2014·Future Oncology·Meaghan L KhanMitesh J Borad
Jul 4, 2012·Current Opinion in Virology·Koki Taniguchi, Satoshi Komoto
Jul 30, 2011·Methods : a Companion to Methods in Enzymology·Karl W BoehmeTerence S Dermody
Dec 14, 2011·Journal of Virological Methods·Virginie Brochu-Lafontaine, Guy Lemay
Jan 1, 2014·Uirusu·Takeshi Kobayashi
Apr 10, 2021·Current Problems in Surgery·John H StewartKonstantinos I Votanopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.